What Researchers Did
Researchers reported a case of a patient with ulcerative colitis and pyoderma gangrenosum successfully treated with hyperbaric oxygen therapy.
What They Found
A patient with ulcerative colitis in remission developed pyoderma gangrenosum that did not improve with antibiotics and daily dressings after two months. Following surgical debridement and three months of hyperbaric oxygen therapy and topical treatment, the patient's pyoderma gangrenosum completely resolved.
What This Means for Canadian Patients
For Canadian patients with pyoderma gangrenosum associated with ulcerative colitis, hyperbaric oxygen therapy may offer an effective alternative treatment option. This could be particularly relevant for those who do not require anti-tumor necrosis factor agents.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
The primary limitation is that this is a single case report, meaning the findings may not be generalizable to all patients with pyoderma gangrenosum associated with ulcerative colitis.